Zhou X - Search Results

1

IMPDH1, a prognostic biomarker and immunotherapy target that correlates with tumor immune microenvironment in pan-cancer and hepatocellular carcinoma.

Liu C, Zhang W, Zhou X, Liu L. Liu C, et al. Among authors: zhou x. Front Immunol. 2022 Dec 22;13:983490. doi: 10.3389/fimmu.2022.983490. eCollection 2022. Front Immunol. 2022. PMID: 36618420 Free PMC article.

2

EBV encoded miRNA BART8-3p promotes radioresistance in nasopharyngeal carcinoma by regulating ATM/ATR signaling pathway.

Zhou X, Zheng J, Tang Y, Lin Y, Wang L, Li Y, Liu C, Wu D, Cai L. Zhou X, et al. Biosci Rep. 2019 Sep 13;39(9):BSR20190415. doi: 10.1042/BSR20190415. Print 2019 Sep 30. Biosci Rep. 2019. PMID: 31471531 Free PMC article.

3

Small extracellular vesicles containing miR-30a-3p attenuate the migration and invasion of hepatocellular carcinoma by targeting SNAP23 gene.

Liu C, Zhou X, Long Q, Zeng H, Sun Q, Chen Y, Wu D, Liu L. Liu C, et al. Among authors: zhou x. Oncogene. 2021 Jan;40(2):233-245. doi: 10.1038/s41388-020-01521-7. Epub 2020 Oct 27. Oncogene. 2021. PMID: 33110233

4

A New Prognostic Strategy Based on four DNA Repair-Associated lncRNAs for Hepatocellular Carcinoma.

Zeng H, Liu C, Zhou X, Liu L. Zeng H, et al. Among authors: zhou x. Comb Chem High Throughput Screen. 2022;25(5):906-918. doi: 10.2174/1386207324666210302091432. Comb Chem High Throughput Screen. 2022. PMID: 33653241

5

HILPDA Is a Prognostic Biomarker and Correlates With Macrophage Infiltration in Pan-Cancer.

Liu C, Zhou X, Zeng H, Wu D, Liu L. Liu C, et al. Among authors: zhou x. Front Oncol. 2021 Mar 18;11:597860. doi: 10.3389/fonc.2021.597860. eCollection 2021. Front Oncol. 2021. PMID: 33816230 Free PMC article.

6

Identification of a thirteen-gene signature predicting overall survival for hepatocellular carcinoma.

Zhou X, Liu C, Zeng H, Wu D, Liu L. Zhou X, et al. Biosci Rep. 2021 Apr 30;41(4):BSR20202870. doi: 10.1042/BSR20202870. Biosci Rep. 2021. PMID: 33835133 Free PMC article.

7

A Pan-Cancer Analysis of CD161, a Potential New Immune Checkpoint.

Zhou X, Du J, Liu C, Zeng H, Chen Y, Liu L, Wu D. Zhou X, et al. Front Immunol. 2021 Jul 9;12:688215. doi: 10.3389/fimmu.2021.688215. eCollection 2021. Front Immunol. 2021. PMID: 34305920 Free PMC article.

8

KNSTRN, a Poor Prognostic Biomarker, Affects the Tumor Immune Microenvironment and Immunotherapy Outcomes in Pan-Cancer.

Zhang W, Liao Y, Liu C, Liu L, Zhou X. Zhang W, et al. Among authors: zhou x. Dis Markers. 2023 Feb 15;2023:6729717. doi: 10.1155/2023/6729717. eCollection 2023. Dis Markers. 2023. PMID: 36845017 Free PMC article.

9

Endoplasmic Reticulum Stress Potentiates the Immunosuppressive Microenvironment in Hepatocellular Carcinoma by Promoting the Release of SNHG6-Enriched Small Extracellular Vesicles.

Liu C, Zhou X, Zeng H, Yu J, Li W, Zhang W, Liao Y, Wang H, Liu L. Liu C, et al. Among authors: zhou x. Cancer Immunol Res. 2024 Sep 3;12(9):1184-1201. doi: 10.1158/2326-6066.CIR-23-0469. Cancer Immunol Res. 2024. PMID: 38900485

10

Comprehensively prognostic and immunological analyses of GLP-1 signaling-related genes in pan-cancer and validation in colorectal cancer.

Zhu C, Lai Y, Liu C, Teng L, Zhu Y, Lin X, Fu X, Lai Q, Liu S, Zhou X, Fang Y. Zhu C, et al. Among authors: zhou x. Front Pharmacol. 2024 Jul 22;15:1387243. doi: 10.3389/fphar.2024.1387243. eCollection 2024. Front Pharmacol. 2024. PMID: 39104385 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53,146 results

Search Page

Filters